Authors:
OBROCEA MM
NASSIM MA
MOLEPO MJ
SHIRAZI FH
GALLANT G
DULUDE H
VINCENT MD
STEWART DJ
GOEL R
Citation: Mm. Obrocea et al., IN-VITRO CARBOPLATIN-MESNA INTERACTION IN AQUEOUS-SOLUTION, HUMAN PLASMA AND URINE, Oncology Reports, 5(6), 1998, pp. 1493-1498
Authors:
SEYMOUR L
GROCHOW L
ECKHARDT G
ERLICHMAN C
HIRTE H
GOEL R
HUMPHREY R
ELIAS I
Citation: L. Seymour et al., CLINICAL AND PHARMACOKINETIC (PK) RESULTS OF 4 PHASE-I STUDIES OF THE2ND-GENERATION MATRIX METALLOPROTEASE (MMP) INHIBITOR BAY-12-9566, A NONPEPTIDIC BIPHENYL INHIBITOR OF MMPS-2, MMPS-3 AND MMPS-9, Annals of oncology, 9, 1998, pp. 601-601
Authors:
HIRTE H
GOEL R
BENNETT K
ELIAS I
SHAH A
SEYMOUR L
Citation: H. Hirte et al., PHASE-I STUDY OF THE MATRIX METALLOPROTEASE INHIBITOR (MMPI) BAY-12-9566 IN PATIENTS WITH ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 286-286
Authors:
SEYMOUR L
HIRTE H
GOEL R
MOORE M
ELIAS I
KUMOR K
HUMPHREY R
Citation: L. Seymour et al., PLANNED AND COMPLETED NCIC CTG TRIALS WITH BAY-12-9566, A NOVEL METALLOPROTEASE INHIBITOR (MMPI), Annals of oncology, 9, 1998, pp. 288-288
Authors:
GINSBURG AD
LEVINE MN
BOWMAN DM
OLIVOTTO IA
FIELDS LA
LITTLE CD
CANTIN J
MCGREGOR M
GOLDHIRSCH A
BRAMWELL V
GELMON K
BRYCE C
ALLAN S
NORRIS B
LATREILLE J
PATERSON ADH
TOMIAK E
TREMBLAY G
BAIRD R
BECKER P
BUTTS C
DANCEY JT
GOEL R
KVERN B
MILNE C
NAROD S
NOLAN E
THURLOW WH
WONG R
Citation: Ad. Ginsburg et al., ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-NEGATIVE BREAST-CANCER, CMAJ. Canadian Medical Association journal, 158, 1998, pp. 43-51
Citation: K. Sachar et al., ACUTE AND CHRONIC EFFECTS OF NICOTINE ON ANASTOMOTIC PATENCY FOLLOWING ISCHEMIA REPERFUSION/, Journal of reconstructive microsurgery, 14(3), 1998, pp. 179-184
Authors:
ROUINI MR
LOTFOLAHI A
STEWART DJ
MOLEPO JM
SHIRAZI FH
VERGNIOL JC
TOMIAK E
DELORME F
VERNILLET L
GIGUERE M
GOEL R
Citation: Mr. Rouini et al., A RAPID REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHODFOR THE DETERMINATION OF DOCETAXEL (TAXOTERE(R)) IN HUMAN PLASMA USING A COLUMN-SWITCHING TECHNIQUE, Journal of pharmaceutical and biomedical analysis, 17(8), 1998, pp. 1243-1247
Citation: R. Goel et al., COMPARISON OF HYDROLYTIC ENZYME-SYSTEMS IN PURE CULTURE AND ACTIVATED-SLUDGE UNDER DIFFERENT ELECTRON-ACCEPTOR CONDITIONS, Water science and technology, 37(4-5), 1998, pp. 335-343
Authors:
RAAPHORST GP
MAO J
YANG H
GOEL R
NIKNAFS B
SHIRAZI FH
YAZDI HM
RIPPSTEIN P
NG CE
Citation: Gp. Raaphorst et al., EVALUATION OF APOPTOSIS IN 4 HUMAN TUMOR-CELL LINES WITH DIFFERING SENSITIVITIES TO CISPLATIN, Anticancer research, 18(4C), 1998, pp. 2945-2951
Authors:
MULLERLISSNER SA
BARTOLO DCC
CHRISTIANSEN J
EKBERG O
GOEL R
HOPFNER W
INFANTINO A
KUIJPERS HC
SELVAGGI F
WALD A
Citation: Sa. Mullerlissner et al., INTEROBSERVER AGREEMENT IN DEFECOGRAPHY - AN INTERNATIONAL STUDY, Zeitschrift fur Gastroenterologie, 36(4), 1998, pp. 273-279
Citation: R. Goel et al., ENZYME-ACTIVITIES UNDER ANAEROBIC AND AEROBIC CONDITIONS INACTIVATED SLUDGE SEQUENCING BATCH REACTOR, Water research (Oxford), 32(7), 1998, pp. 2081-2088
Authors:
WARNER E
GOEL R
CHANG J
CHOW W
VERMA S
DANCEY J
FRANSSEN E
DULUDE H
GIROUARD M
CORREIA J
GALLANT G
Citation: E. Warner et al., A MULTICENTER PHASE-II STUDY OF CARBOPLATIN AND PROLONGED ORAL ETOPOSIDE IN THE TREATMENT OF CANCER OF UNKNOWN PRIMARY SITE (CUPS), British Journal of Cancer, 77(12), 1998, pp. 2376-2380
Authors:
LAL BN
NAGHAVI M
GOEL R
MALIK B
COSTAS G
CLUBB FJ
WILLERSON JT
Citation: Bn. Lal et al., INDUCTION OF APOPTOSIS IN MACROPHAGES IN HUMAN CAROTID ATHERECTOMY SPECIMENS BY GENTLE HEATING, The American journal of cardiology, 82, 1998, pp. 105-105
Authors:
STEWART DJ
GOEL R
CRIPPS MC
YAU J
HUAN S
TOMIAK E
DAVIES RA
DULUDE H
GALLANT G
Citation: Dj. Stewart et al., CONCURRENT USE OF MULTIPLE CHEMOTHERAPY RESISTANCE MODULATORS WITH ETOPOSIDE IN PATIENTS WITH RESISTANT MALIGNANCIES, International journal of oncology, 11(4), 1997, pp. 709-716
Authors:
STEWART DJ
CRIPPS MC
GOEL R
DAHROUGE S
YAU J
TOMIAK E
HUAN S
SOLTYS K
PROSSER A
DAVIES RA
Citation: Dj. Stewart et al., PILOT-STUDY OF MULTIPLE CHEMOTHERAPY RESISTANCE MODULATORS PLUS EPIRUBICIN IN THE TREATMENT OF RESISTANT MALIGNANCIES, Cancer chemotherapy and pharmacology, 41(1), 1997, pp. 1-8
Authors:
STEWART DJ
DULBERG CS
MIKHAEL NZ
REDMOND MD
MONTPETIT VAJ
GOEL R
Citation: Dj. Stewart et al., ASSOCIATION OF CISPLATIN NEPHROTOXICITY WITH PATIENT CHARACTERISTICS AND CISPLATIN ADMINISTRATION METHODS, Cancer chemotherapy and pharmacology, 40(4), 1997, pp. 293-308
Authors:
MATHEWS J
GOEL R
EVANS WK
SHAMJI F
STEWART DJ
Citation: J. Mathews et al., ARTERIAL-OCCLUSION IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE TREATED WITH PLATINUM-BASED REGIMENS FOR LUNG-CANCER, Cancer chemotherapy and pharmacology, 40(1), 1997, pp. 19-22
Citation: R. Goel et al., RECEPTOR-C-K DEPENDENT SIGNALING REGULATES THE LDL-RECEPTOR GENE-TRANSCRIPTION, Molecular and cellular biochemistry, 169(1-2), 1997, pp. 79-83
Authors:
MAROUN JA
CRIPPS C
GOEL R
DAHROUGE S
BOISVERT D
Citation: Ja. Maroun et al., RETROSPECTIVE COMPARATIVE-ANALYSIS OF 5FU PLUS LOW-DOSE FOLINIC ACID VS 5FU PLUS HIGH-DOSE FOLINIC ACID IN THE TREATMENT OF METASTATIC COLORECTAL-CANCER - THE OTTAWA EXPERIENCE, American journal of clinical oncology, 20(4), 1997, pp. 387-392
Authors:
EVANS WK
EARLE CC
STEWART DJ
DAHROUGE S
TOMIAK E
GOSS G
LOGAN D
GOEL R
GERTLER SZ
DULUDE H
Citation: Wk. Evans et al., PHASE-II STUDY OF A ONE-HOUR PACLITAXEL INFUSION IN COMBINATION WITH CARBOPLATIN FOR ADVANCED NONSMALL CELL LUNG-CANCER, Lung cancer, 18(1), 1997, pp. 83-94
Authors:
STEWART DJ
GOEL R
CRIPPS MC
HUAN S
YAU J
VERMA S
Citation: Dj. Stewart et al., MULTIPLE RESISTANCE MODULATORS COMBINED WITH CARBOPLATIN FOR RESISTANT MALIGNANCIES - A PILOT-STUDY, Investigational new drugs, 15(4), 1997, pp. 267-277